T1	Participants 513 572	153 patients in pCR following platinum-based intravenous CT
T2	Participants 918 1145	two groups were well balanced in terms of age (median = 55 years), performance status (78% P.S. O), FIGO stage (96% stage III), histology (serous in 66%), grade (2 or 3 in 80%), and residuum before intravenous CT (>1 cm in 40%)
T3	Participants 118 141	ovarian cancer patients
